Evidence map›Paper›PMID 29801898›Full record

ArticleJournal of the neurological sciences2018

Non-right handed primary progressive apraxia of speech.

Hugo Botha, Joseph R Duffy, Jennifer L Whitwell, Edythe A Strand, Mary M Machulda, Anthony J Spychalla, Nirubol Tosakulwong, Matthew L Senjem, David S Knopman, Ronald C Petersen and 3 more

Abstract read
In one paragraph

Article in Journal of the neurological sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Hugo BothaDepartment of Neurology (Behavioral Neurology), Mayo Clinic, Rochester, MN 55905, USA.
Joseph R DuffyDepartment of Neurology (Speech Pathology), Mayo Clinic, Rochester, MN 55905, USA.
Jennifer L WhitwellDepartment of Radiology (Neuroradiology), Mayo Clinic, Rochester, MN 55905, USA.
Edythe A StrandDepartment of Neurology (Speech Pathology), Mayo Clinic, Rochester, MN 55905, USA.
Mary M MachuldaDepartment of Psychiatry and Psychology (Neuropsychology), Mayo Clinic, Rochester, MN 55905, USA.
Anthony J SpychallaDepartment of Radiology (Neuroradiology), Mayo Clinic, Rochester, MN 55905, USA.
Nirubol TosakulwongDepartment of Health Sciences Research (Biostatistics), Mayo Clinic, Rochester, MN, USA.
Matthew L SenjemDepartment of Radiology (Neuroradiology), Mayo Clinic, Rochester, MN 55905, USA; Department of Information Technology, Mayo Clinic, Rochester, MN, 55905, USA.
David S KnopmanDepartment of Neurology (Behavioral Neurology), Mayo Clinic, Rochester, MN 55905, USA.
Ronald C PetersenDepartment of Neurology (Behavioral Neurology), Mayo Clinic, Rochester, MN 55905, USA.
Clifford R JackDepartment of Radiology (Neuroradiology), Mayo Clinic, Rochester, MN 55905, USA.
Val J LoweDepartment of Radiology (Nuclear Medicine), Mayo Clinic, Rochester, MN 55905, USA.
Keith A JosephsDepartment of Neurology (Behavioral Neurology), Mayo Clinic, Rochester, MN 55905, USA; Department of Neurology (Movement Disorders), Mayo Clinic, Rochester, MN 55905, USA. Electronic address: josephs.keith@mayo.edu.
Mayo Clinic in Arizona · USMayo Clinic · USMayo Clinic in Florida · US

Funding

SUPPLEMENT TO ALZHEIMERS DISEASE PATIENT REGISTRYU01AG006786 · NIA · MAYO CLINIC ROCHESTER · PI GRAFF-RADFORD, JONATHAN, JACK, CLIFFORD R. · 1986 to 2023
$49.6M
PREDICTING ALZHEIMERS DISEASE WITH MAGNETIC RESONANCER01AG011378 · NIA · MAYO CLINIC ROCHESTER · PI JACK, CLIFFORD R. · 1993 to 2017
$12.1M
Longitudinal multi-modality imaging in progressive apraxia of speech (Diversity Supplement)R01DC012519 · NIDCD · MAYO CLINIC ROCHESTER · PI Jennifer Louise Whitwell · 2013 to 2026
$7.2M
Validating the New Criteria for Preclinical Alzheimer's diseaseR01AG041851 · NIA · MAYO CLINIC ROCHESTER · PI JACK, CLIFFORD R., KNOPMAN, DAVID S · 2012 to 2021
$6.3M
PIB PET Scanning in Speech and Language Based DementiasR01DC010367 · NIDCD · MAYO CLINIC ROCHESTER · PI JOSEPHS, KEITH A · 2010 to 2014
$1.7M
Assessment of hyperphosphorylated tau PET binding in primary progressive aphasiaR21NS094684 · NINDS · MAYO CLINIC ROCHESTER · PI JOSEPHS, KEITH A · 2016 to 2017
$417k
NIA NIH HHS R01 AG011378NIA NIH HHS R01 AG041851NIA NIH HHS U01 AG006786NIDCD NIH HHS R01 DC010367NIDCD NIH HHS R01 DC012519NINDS NIH HHS R21 NS094684
6 · The paper itself

Abstract

In recent years a large and growing body of research has greatly advanced our understanding of primary progressive apraxia of speech. Handedness has emerged as one potential marker of selective vulnerability in degenerative diseases. This study evaluated the clinical and imaging findings in non-right handed compared to right handed participants in a prospective cohort diagnosed with primary progressive apraxia of speech. A total of 30 participants were included. Compared to the expected rate in the population, there was a higher prevalence of non-right handedness among those with primary progressive apraxia of speech (6/30, 20%). Small group numbers meant that these results did not reach statistical significance, although the effect sizes were moderate-to-large. There were no clinical differences between right handed and non-right handed participants. Bilateral hypometabolism was seen in primary progressive apraxia of speech compared to controls, with non-right handed participants showing more right hemispheric involvement. This is the first report of a higher rate of non-right handedness in participants with isolated apraxia of speech, which may point to an increased vulnerability for developing this disorder among non-right handed participants. This challenges prior hypotheses about a relative protective effect of non-right handedness for tau-related neurodegeneration. We discuss potential avenues for future research to investigate the relationship between handedness and motor disorders more generally.

Indexed as

Functional LateralityAgedAphasia, Primary ProgressiveBrainFemaleFluorodeoxyglucose F18HumansImaging, Three-DimensionalMalePositron-Emission TomographyProspective StudiesRadiopharmaceuticalsRisk FactorsFluorodeoxyglucose F18RadiopharmaceuticalsFDG-PET imagingHandednessPrimary progressive aphasiaProgressive apraxia of speech

Identifiers

PMID29801898
PMCPMC5986290
OpenAlexW2802055965

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.